Microsoft word - lcl.doc


SECTION 1 : CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

Product Name

Lithium Chloride
Product Code 333 001
Synonyms
Molecular Weight
Chemical Formula

Contact Information

MFPL Fluorine Products Ltd
E-mail : [email protected] / SECTION 2 : COMPOSITION / INFORMATION ON INGREDIENTS

Ingredient CAS No Percent Hazardous

Lithium Chloride 7447-41-8 100% Yes
SECTION 3 : Hazards Identification

Emergency Overview
Warning! harmful if swallowed or inhaled. affects central nervous system, respiratory system, muscles and kidneys. causes irritation to skin, eyes and respiratory tract. skin irritation may be
SAF-T-DATA(tm) Ratings (Provided here for your convenience)
Lab Protective Equip: GOGGLES; LAB COAT; VENT HOOD; PROPER GLOVES Storage Color Code: Green (General Storage)
Potential Health Effects Inhalation:
Causes irritation to the respiratory tract. Can be absorbed through inhalation with symptoms to Ingestion:
Causes irritation to the gastrointestinal tract. Symptoms may include nausea, vomiting and diarrhea. In severe cases, lithium can cause apathy, sluggishness, drowsiness, slurred speech, blurred vision, irregular eye movements, weakness, incoordination, lethargy, heart effects, brain effects, ringing in the ears, tremors and muscle twitching, central nervous system damage, kidney effects, thyroid changes, coma, pulmonary edema, and renal failure. Skin Contact:
Causes irritation to skin. Irritation may be severe. Eye Contact:
Chronic Exposure:
Prolonged or repeated ingestion may cause symptoms paralleling ingestion. Death may occur Aggravation of Pre-existing Conditions:

SECTION 4 : FIRST AID MEASURES
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Call a physician immediately. Ingestion:
Induce vomiting immediately as directed by medical personnel. Never give anything by mouth to an unconscious person. Call a physician immediately. Skin Contact:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes. Remove contaminated clothing and shoes. Wash clothing before reuse. Call a physician. Eye Contact:
Wash eyes with plenty of water for at least 15 minutes. Call a physician SECTION 5 : FIRE-FIGHTINGS MEASURES
Fire:
Not considered to be a fire hazard.

Explosion :
Not considered to be an explosion hazard.

Fire Extinguishing Media:
Use any means suitable for extinguishing surrounding fire.
Special Information: In the event of a fire, wear full protective clothing and NIOSH-approved
self-contained breathing apparatus with full facepiece operated in the pressure demand or other
SECTION 6 : ACCIDENTAL RELEASE MEASURES
Ventilate area of leak or spill. Wear appropriate personal protective equipment as specified in Section 8. Spills: Pick up and place in a suitable container for reclamation or disposal, using a
SECTION 7 : HANDLING AND STORAGE
Keep in a tightly closed container, stored in a cool, dry, ventilated area. Protect against physical damage. Containers of this material may be hazardous when empty since they retain product residues (dust, solids); observe all warnings and precautions listed for the product.
SECTION 8 : EXPOSURE CONTROLS / PERSONAL PROTECTION
Airborne Exposure Limits:
VentilationSystem:
A system of local and/or general exhaust is recommended to keep employee exposures as low as possible. Local exhaust ventilation is generally preferred because it can control the emissions of the contaminant at its source, preventing dispersion of it into the general work area. Please refer to the ACGIH document, Industrial Ventilation, A Manual of Recommended Practices, most Personal Respirators (NIOSH Approved):
For conditions of use where exposure to dust or mist is apparent and engineering controls are not feasible, a particulate respirator (NIOSH type N95 or better filters) may be worn. If oil particles (e.g. lubricants, cutting fluids, glycerine, etc.) are present, use a NIOSH type R or P filter. For emergencies or instances where the exposure levels are not known, use a full-face positive- pressure, air-supplied respirator. WARNING: Air-purifying respirators do not protect workers in Skin Protection:
Wear impervious protective clothing, including boots, gloves, lab coat, apron or coveralls, as Eye Protection:
Use chemical safety goggles. Maintain eye wash fountain and quick-drench facilities in work
SECTION 9 : PHYSICAL AND CHEMICAL PROPERTIES
Appearance White crystals
Solubility
Specific Gravity
Aqueous solution is neutral or slightly alkaline % Volatiles by volume @ 21C (70F) 0
Boiling Point
Melting Point
Vapor Density (Air=1)
Vapor Pressure (mm Hg)
Evaporation Rate (BuAc=1)

SECTION 10 : STABILITY AND REACTIVITY
Stability:
Stable under ordinary conditions of use and storage. Hazardous Decomposition Products:
Emits toxic fumes of chlorine when heated to decomposition. Hazardous Polymerization:
Incompatibilities:
Conditions to Avoid:
SECTION 11 : TOXICOLOGICAL INFORMATION
Toxicological Data:
Oral rat LD50: 526 mg/kg. Investigated as a tumorigen, mutagen, and reproductive effector. Reproductive Toxicity:
Has shown some evidence of reproductive effects in laboratory animals.
--------\Cancer Lists\------------------------------------------------------
---NTP Carcinogen---
Ingredient Known Anticipated IARC Category
------------------------------------ ----- ----------- -------------
Lithium Chloride (7447-41-8) No No None
SECTION 12 : ECOLOGICAL INFORMATION
Environmental Fate:
Environmental Toxicity:
Oral (wild bird) LD50: 422 mg/kg (RTECS, 1995)
SECTION 13 : DISPOSAL CONSIDERATIONS
Whatever cannot be saved for recovery or recycling should be managed in an appropriate and approved waste disposal facility. Processing, use or contamination of this product may change the waste management options. State and local disposal regulations may differ from federal disposal regulations. Dispose of container and unused contents in accordance with federal, state
SECTION 14. TRANSPORT INFORMATION
SECTION 15 : REGULATORY INFORMATION
--------\Chemical Inventory Status - Part 1\--------------------------------- Ingredient TSCA EC Japan Australia ----------------------------------------------- ---- --- ----- --------- Lithium Chloride (7447-41-8) Yes Yes Yes Yes -------\Chemical Inventory Status - Part 2\--------------------------------- --Canada-- Ingredient Korea DSL NDSL Phil. ----------------------------------------------- ----- --- ---- ----- Lithium Chloride (7447-41-8) Yes Yes No Yes --------\Federal, State & International Regulations - Part 1\---------------- -SARA 302- ------SARA 313------ Ingredient RQ TPQ List Chemical Catg. ----------------------------------------- --- ----- ---- -------------- Lithium Chloride (7447-41-8) No No No No --------\Federal, State & International Regulations - Part 2\---------------- -RCRA- -TSCA- Ingredient CERCLA 261.33 8(d) ----------------------------------------- ------ ------ ------ Lithium Chloride (7447-41-8) No No No Chemical Weapons Convention: No TSCA 12(b): No CDTA: No SARA 311/312: Acute: Yes Chronic: Yes Fire: No Pressure: No Reactivity: No (Pure / Solid) Australian Hazchem Code: None allocated.
Poison Schedule: None allocated.
This MSDS has been prepared according to the hazard criteria of the Controlled Products Regulations (CPR) and the MSDS contains all of the information required by the CPR. SECTION 16 : OTHER INFORMATION
Creation Date : 18.9.2000

Revision Date
: 25.7.2006

Disclaimer:

MFPL Fluorine Products Ltd. provides the information contained herein in good faith but makes no
representation as to its comprehensiveness or accuracy. This document is intended only as a
guide to the appropriate precautionary handling of the material by a properly trained person using
this product. Individuals receiving the information must exercise their independent judgment in
determining its appropriateness for a particular purpose. MFPL Fluorine Products Ltd MAKES NO
REPRESENTATIONS OR WARRANTIES, EITHER EXPRESS OR IMPLIED, INCLUDING WITHOUT
LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE
WITH RESPECT TO THE INFORMATION SET FORTH HEREIN OR THE PRODUCT TO WHICH THE
INFORMATION REFERS. ACCORDINGLY, MFPL Fluorine Products Ltd WILL NOT BE
RESPONSIBLE FOR DAMAGES RESULTING FROM USE OF OR RELIANCE UPON THIS
INFORMATION

Source: http://www.mfplfluorine.co.in/products/lithiumproducts/lithiumchloride.pdf

Ddb.11.0

Daniel de Beer Né le 18 octobre 1953 Belge Rue du Viaduc 35 1050 Bruxelles Tél. : + 32.(0)2.646 42 27 Courriel : [email protected] Licencié en droit (1977 - UCL) Docteur en droit (juin 2008 - VUB) Activités professionnelles - professeur invité aux Facultés Universitaires Saint Louis (cours de « Sources et principes du droit » ; séminaire interdisciplinaire et Séminair

Untitled

International Journal of Drug Design and Discovery Volume 1 • Issue 2 • April– June 2010. 115-123 Synthesis and in vitro Biological Activity of Organic Charge-transfer Complexes of lansoprazole, fluconazole, gabapentin and gabalactum with Chloranilic and Picric Acids Lingappa Mallesha and Kikkeri N. Mohana* Department of Studies in Chemistry, University o

Copyright © 2010-2014 Medical Articles